NCT07893158

A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker Volunteers

← Clinical trials hub

Registry fields

Overall status
RECRUITING
Conditions
Smoking Cessation, Nicotine Replacements Therapy
Study type
INTERVENTIONAL
Phase
PHASE2
Primary purpose
TREATMENT
Intervention type
DRUG
Interventions
Nicotine Mint Oro Dispersible Tablet (Nic ODT), Placebo Oro Dispersible Tablet (Placebo ODT)
Lead sponsor
McNeil AB (INDUSTRY)

Cached at: 2026-10-24 01:13:29

View on ClinicalTrials.gov

Brief summary

The objective of the study is to evaluate the relief of momentary urge to smoke at pre-specified early post-dose time points after administration of Nic ODT compared to Placebo ODT.

Contact

Need a report or Korean medical writing based on this trial?

Contact Support